Codexis Inc. (0I0X)
LSE
Closed
Oct 13, 2026
Day's Range
1.3452 wk Range
0.9646Overview - 0I0X - Codexis Inc.
Key Statistics
Valuation
Enterprise Value
168.23M
Price / Book
3.80
EV / EBITDA
-8.83
Profitability
Profit Margin
-39.55%
Operating Margin
-75.28%
Return on Assets
-11.73%
Return on Equity
-69.36%
Ownership
Shares Outstanding
54.01M
Float
82.34M
Held by Insiders
7.11%
Held by Institutions
70.48%
Price stats
Beta
2.52
50-Day Avg
3.10
200-Day Avg
2.51
Market Cap - 0I0X - Codexis Inc.
Peers - 0I0X - Codexis Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0I0XLSECodexis Inc.74.27MMarket Cap-83.19%52-week change—P/E (Trailing)-39.55%Profit Margin
- 0MGBLSEGenmab A/S207.40BMarket Cap+25.18%52-week change36.60P/E (Trailing)29.01%Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock129.06BMarket Cap+14.69%52-week change52.74P/E (Trailing)34.99%Profit Margin
- 0A45LSEModerna Inc.107.69BMarket Cap+88.04%52-week change84.05P/E (Trailing)11.32%Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.81.30BMarket Cap+23.54%52-week change10.70P/E (Trailing)27.86%Profit Margin
- 0QW0LSEargenx SE43.34BMarket Cap+6.62%52-week change34.95P/E (Trailing)-47.51%Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.62%52-week change120.56P/E (Trailing)6.45%Profit Margin
Profile Summary - 0I0X - Codexis Inc.
About
Codexis Inc. is a biotechnology company focused on enzyme engineering and biocatalysis. Codexis develops and commercializes proprietary protein engineering technologies that create tailored enzymes for pharmaceutical manufacturing, RNA synthesis, molecular biology, diagnostics, and other life sciences applications.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
